E. Garry Menzel - Dec 15, 2022 Form 4 Insider Report for TCR2 THERAPEUTICS INC. (TCRR)

Role: President and CEO, Director
Signature: /s/ Margaret Siegel as Attorney-in-Fact
Stock symbol: TCRR
Transactions as of: Dec 15, 2022
Transactions value $: $0
Form type: 4
Date filed: 12/19/2022, 04:32 PM
Previous filing: Dec 13, 2022
Next filing: May 17, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	TCRR	Common Stock						133K	Dec 15, 2022	See Footnote	F1
holding	TCRR	Common Stock						133K	Dec 15, 2022	See Footnote	F2
holding	TCRR	Common Stock						139K	Dec 15, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	TCRR	Stock Option (Right to Buy)	Award	$0	+238K		$0.00	238K	Dec 15, 2022	Common Stock	238K	$0.97	Direct	F3
transaction	TCRR	Restricted Stock Unit (Right to Buy)	Award	$0	+39.7K		$0.00	39.7K	Dec 15, 2022	Common Stock	39.7K		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of 132,729 shares of common stock held by the Garry E. Menzel Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Menzel Trust"). The reporting person is the trustee of the Menzel Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Menzel Trust.
F2	Consists of 132,730 shares of common stock held by and the Mary E. Henshall Revocable Trust of 2022, under Indenture of Trust dated April 5, 2022 (the "Henshall Trust"). The reporting person's spouse is the trustee of the Henshall Trust, and as such the reporting person may be deemed to beneficially own such securities. The reporting person and members of his immediate family are the sole beneficiaries of the Henshall Trust.
F3	25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
F4	Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
F5	The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.